ArriVent BioPharma, Inc. AVBP Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by ArriVent BioPharma, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.
The official record: ArriVent BioPharma, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about ArriVent BioPharma, Inc.'s prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ArriVent BioPharma, Inc.'s prepaid & other current?
- ArriVent BioPharma, Inc. (AVBP) reported prepaid & other current of $22.32M in Q1 2026.
- How has ArriVent BioPharma, Inc.'s prepaid & other current changed year-over-year?
- ArriVent BioPharma, Inc.'s prepaid & other current increased by 129.9% year-over-year, from $9.71M to $22.32M.
- What is the long-term trend for ArriVent BioPharma, Inc.'s prepaid & other current?
- Over 2 years (2023 to 2025), ArriVent BioPharma, Inc.'s prepaid & other current has grown at a 306.3% compound annual growth rate (CAGR), from $3.95M to $65.2M.
- What does prepaid & other current mean?
- Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.